PFIZER INC (PFE)
Health Care / Pharmaceuticals
S&P 500$26.50
Middle of the pack. No strong signal either way.
Consider Buy
Score based on 5 of 5 models — high confidence
Is PFIZER INC a Good Investment in 2026?
PFIZER INC (PFE) scores 5.6 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Greenblatt Magic Formula model rates PFIZER INC as Strong (Top 10% (rank 4%)). However, the Graham model rates it Caution — 22% above fair value. PFIZER INC currently trades below its estimated fair value of $33, suggesting potential upside. PFIZER INC ranks #369 out of 1126 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Fair value above market price. P/E of 19x is moderate for this quality level.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Attractive
5/9
Buffett
Attractive
Business quality & competitive moat
Graham
Caution
22% above fair value
Lynch
Neutral
High PEG — growth premium · Slow Grower
Greenblatt
Strong
Top 10% (rank 4%)
Frequently Asked Questions
Is PFIZER INC (PFE) a good investment?
What is PFIZER INC's Piotroski F-Score?
Is PFE overvalued or undervalued?
How does PFE compare to other Health Care stocks?
What do investment models say about PFE?
Similar Stocks
Compare PFE with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer